Ajanta Pharma

Ajanta Pharma
Ajanta Pharma
Shareholder Return: 3-year, Sales Growth: 3-year CAGR, Return On Equity: 3-year average
At a Glance
  • Shareholder Return
    354%
  • Sales Growth
    18%
  • Return on Equity
    40 %

Why Super 50

Brothers Yogesh and Rajesh Agrawal have transformed the beleaguered business, founded by their father and uncles in 1973, into one of India's fastest growing generic pharmaceutical companies by focusing on niche and specialty generic drugs. Having established a firm hold on markets in Asia and Africa, Ajanta has trained its sight on the lucrative US market, where its sales and filings of new drugs have risen sharply.



More Stories